PPTC7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.97180005446063E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.76000003249533E-09 |
Normal-vs-Stage2 |
6.44419999999979E-05 |
Normal-vs-Stage3 |
5.30160000011826E-07 |
Normal-vs-Stage4 |
2.14649999999983E-05 |
Stage1-vs-Stage2 |
6.990000E-01 |
Stage1-vs-Stage3 |
6.970800E-01 |
Stage1-vs-Stage4 |
3.992400E-01 |
Stage2-vs-Stage3 |
4.920000E-01 |
Stage2-vs-Stage4 |
2.747000E-01 |
Stage3-vs-Stage4 |
5.463400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.60900001602948E-09 |
Normal-vs-AfricanAmerican |
2.59430000004723E-06 |
Normal-vs-Asian |
1.9345399999926E-05 |
Caucasian-vs-AfricanAmerican |
3.920800E-01 |
Caucasian-vs-Asian |
2.446800E-01 |
AfricanAmerican-vs-Asian |
1.196010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.29950000654833E-09 |
Normal-vs-Female |
3.75580000000486E-06 |
Male-vs-Female |
3.523600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.57320000254902E-08 |
Normal-vs-Extreme_Weight |
6.00539951101098E-10 |
Normal-vs-Obese |
3.67300000000403E-05 |
Normal-vs-Extreme_Obese |
1.601730E-03 |
Normal_Weight-vs-Extreme_Weight |
8.754400E-01 |
Normal_Weight-vs-Obese |
5.646200E-02 |
Normal_Weight-vs-Extreme_Obese |
4.505000E-01 |
Extreme_Weight-vs-Obese |
4.680000E-02 |
Extreme_Weight-vs-Extreme_Obese |
5.052400E-01 |
Obese-vs-Extreme_Obese |
7.304000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.63716000000091E-05 |
Normal-vs-Age(41-60Yrs) |
3.90219999979458E-07 |
Normal-vs-Age(61-80Yrs) |
1.85140003328144E-09 |
Normal-vs-Age(81-100Yrs) |
6.03499999999313E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.346200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.510200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.070000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.725600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.064600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.442400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.34579999869311E-08 |
Normal-VS-Type2 PRCC |
1.64250000045385E-07 |
Normal-VS-KIRP CIMP |
1.605820E-04 |
Normal-VS-Unclassified PRCC |
1.701930E-03 |
Type1 PRCC-VS-Type2 PRCC |
9.399200E-01 |
Type1 PRCC-VS-KIRP CIMP |
8.798200E-01 |
Type1 PRCC-VS-Unclassified PRCC |
1.324020E-01 |
Type2 PRCC-VS-KIRP CIMP |
9.070200E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.660760E-01 |
KIRP CIMP-VS-Unclassified PRCC |
3.784000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.82530015943894E-10 |
Normal-vs-N1 |
6.8442000000779E-07 |
Normal-vs-N2 |
1.158040E-03 |
N0-vs-N1 |
4.968000E-01 |
N0-vs-N2 |
7.802200E-01 |
N1-vs-N2 |
5.443800E-01 |
|
|